Original paper
Harmful cytokines in cancer immunology and immunotherapy: biomarkers and targets?
Abstract
Immune checkpoint inhibitors (ICI) represented a major breakthrough for the treatment of human cancer. Most patients, however, do not benefit from treatment with these agents, thus making it necessary to identify biomarkers that allow a better stratification of patients based on their potential sensitivity to ICI. Cytokines are protein mediators of cell-to-cell communication usually acting in a paracrine fashion involving their release to the...
Paper Details
Title
Harmful cytokines in cancer immunology and immunotherapy: biomarkers and targets?
Published Date
Nov 1, 2021
Journal
Volume
32
Issue
11
Pages
1311 - 1313
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History